No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SAVA240712C13000
- 0.08
- -0.07-46.67%
15min DelayClose Jul 8 16:00 ET
0.23High0.04Low
0.23Open0.15Pre Close240 Volume310 Open Interest13.00Strike Price3.49KTurnover182.16%IV32.93%PremiumJul 12, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type0.0951Delta0.0871Gamma123.00Leverage Ratio-0.0358Theta0.0001Rho11.70Eff Leverage0.0018Vega
Intraday
- 5D
- Daily
News
Top 5 Health Care Stocks That May Explode In July
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Express News | FDA Approves Kisunla For Early Symptomatic Alzheimer's Disease; Phase 3 Study Shows Kisunla Slowed Cognitive And Functional Decline By Up To 35% And Reduced Risk Of Disease Progression By Up To 39%; Once-Monthly Infusions Reduced Amyloid Plaques By...
Cassava Forms Committee After US Probe, Researcher Fraud
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Why Cassava Sciences Stock Is Sinking Today
Cassava Sciences Down Another 3% as SEC Provides Update on Simufilam Probe
Comments
$Cassava Sciences(SAVA.US$ The benefits of repairing misfolded protein ’Sava: Simufilam’ as opposed to removing amyloid plaques other company drugs keep doing that causes brain bleeding, brain swelling and some, death.
$Cassava Sciences(SAVA.US$ Crucial conflict of Interest details between Rapport Therapeutics founder that has co-founder on NIH Board and short Selling SAVA Stock. In summary, the conflicts of interest stem from Bredt’s dual role in financially benefiting from Cassava's potential failure (through short selling) and professionally advancing a competing Alzheimer’s treatment, which could be seen as motivations for filing the Citizen's Petition against Cassava Sciences.
1
$Cassava Sciences(SAVA.US$ The conflict of interest or alleged corruption from those opposing Cassava Sciences is very easy to trace. People panic on clickbait FUD headlines without doing their research. Rapport Company that is against SAVA, founder and chairman Steve Paul is also chairman of the board of the foundation for the NIH. His co-founder David Bredt, is the One who made that Citizen's Petition and using a lot of the same mechanisms as SAVA with their company but claim that he never in...
1
$Cassava Sciences(SAVA.US$ These are Caregivers speaking out. Thank to Matt N. SAVA's simufilam is working . All of those Fud, Hedge Funds & shorts are clearly manipulating the reputation and stock price of this company because it is actually treating AD patients and shorts have been trying to stop this. Do Not let them destroy the only safe drug with efficacy for AD patients. Phase 3 trials are almost done and plenty of people are improving.
2
Read more